A clinical study of a stroke risk score model based on atrial high frequency event and left atrial function

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036526

Enrollment

Unknown

Registered

2020-08-24

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

Events group:Nil

zero-event group:Nil

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Aged >=18 years, no gender limit; 2) A pacemaker DDD(R) that can provide daily atrial electrical activity data records has been implanted; 3) Not diagnosed as clinical atrial fibrillation; 4) Volunteer to participate in this trial, voluntarily follow the follow-up and evaluation procedures of this trial, and sign a written informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients who plan to undergo heart surgery or are on the heart transplant list within the next 6 months; 2) Heart failure patients with New York Heart Disease Classification 3-4, or LVEF < 50%; 3) Patients with reversible causes of atrial fibrillation such as hyperthyroidism and severe postoperative atrial fibrillation; 4) Patients diagnosed with persistent atrial fibrillation; 5) Patients whose life expectancy is less than 1 year; 6) The patient plans to become pregnant or breastfeeding within the next year; 7) Patients with unstable and decompensated heart failure (pulmonary edema, hypoperfusion or hypotension); 8) Cancer patients.

Design outcomes

Primary

Measure	Time frame
Embolic Events;Cardiovascular mortality and total mortality;	—

Countries

China

Contacts

Public ContactGao Wen

Huashan Hospital, Fudan University

gaowen0203@yahoo.com+86 18818210731

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026